Guggenheim Rates DoorDash (DASH) buy, $255 Price Target

Analyst Taylor Manley keeps a buy rating and $255 price target on DoorDash, aligning with broader Wall Street sentiment, a 44.40% upside from the current price.

By TradeTexts Research Desk · Published Jun 23, 2026, 9:01 AM EDT · Updated Jun 26, 2026, 6:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Guggenheim rated DoorDash, Inc. ($DASH) "buy" with a $255 price target on June 23, 2026.

Since the rating, $DASH is up 7.6% after 1 week, down 1.0% after 1 month and up 10.3% to date (from the $171.52 close on Jun 23, 2026).

DASH DoorDash, Inc.

$189.15 -13.94% year to date

Daily close · Oct 16, 2026

Key Points

Guggenheim maintained its buy rating and $255 price target on DoorDash, Inc. on October 14, 2026.
Guggenheim's $255 price target implies 44.40% upside from DoorDash, Inc.'s ($DASH) current $176.59 share price.
DoorDash shares trade around $176.59, below their 50-day moving average of $205.69 and within a 52-week range of $143.30 to $269.00.
Wall Street maintains a consensus buy recommendation for DoorDash with an average price target of $257.37 across 42 analysts.

Get $DASH trade alerts by text

We text you when insiders, Congress or big funds trade $DASH. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated DoorDash, Inc. alert may contain errors. Disclosures

Guggenheim Reasserts View on DoorDash Shares

Guggenheim analyst Taylor Manley reaffirmed a buy rating on DoorDash, Inc. (NasdaqGS: DASH) along with a price target of $255.00 on October 14, 2026. This call places the firm right in line with the broader analyst community covering the digital commerce platform, which connects merchants, consumers, and delivery workers across global markets.

12-month forecast

$DASH price target

DoorDash, Inc. daily closes and this analyst's $255 target. Not advice.

Where Wall Street Stands on DoorDash

Other major financial institutions have also weighed in on the delivery network recently, showing a mix of bullish and cautious stances. On October 12, 2026, Cantor Fitzgerald maintained its overweight rating while moving its price target from $260.00 to $240.00. Wells Fargo kept an equal-weight rating on October 5, 2026, lifting its target from $225.00 to $230.00. Earlier in September, Scotiabank initiated coverage with a sector outperform rating and a $275.00 target, while StoneX kept a buy rating and a $295.00 target on September 8, 2026. Rosenblatt also started coverage on September 1, 2026, with a buy rating and a $270.00 target. Wedbush and Roth Capital both maintain neutral ratings on the stock, with price targets sitting at $220.00.

Market Position and Stock Activity

DoorDash shares trade at $176.59 as of Tuesday, sitting well below their 50-day moving average of $205.69 and their 200-day moving average of $185.17. The stock has moved through a 52-week range spanning from a low of $143.30 up to a high of $269.00. With a market capitalization of roughly $83.65 billion, the company trades at a forward P/E ratio of 23.40.

Q3 Financial Results on the Horizon

DoorDash is scheduled to report its next set of quarterly financial results on November 4, 2026, after the market closes. Investors will be reviewing revenue growth, profit margins, and order volume metrics following its reported annual revenue of $15.89 billion and net income margins of 5.29% over prior periods.

About DoorDash

Based in San Francisco, California, DoorDash operates online commerce platforms including DoorDash Marketplace, Wolt Marketplace, and Deliveroo Marketplace. The company provides merchants with customer acquisition, demand generation, order fulfillment, payment processing, and white-label delivery solutions alongside consumer subscription programs like DashPass.

What to Watch at DoorDash, Inc.

The upcoming earnings report on November 4 will give investors a fresh look at the company's financial health and order volumes. Market participants will also monitor whether additional research firms adjust their price targets to match the prevailing consensus average of $257.37.